APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Drug and Delivery Technologies

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Drug and Delivery Technologies Industry Growth and Trends Forecast to 2032

Report ID 174003550122 December 202598 pages

Choose your research edition.

Industry ResearchInsulin Drug and Delivery Technologies Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Drug and Delivery Technologies Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Insulin Drug and Delivery Technologies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Drug and Delivery Technologies Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Drug and Delivery Technologies Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Insulin Drug and Delivery Technologies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Drug and Delivery Technologies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Drug and Delivery Technologies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Drug and Delivery Technologies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Drug and Delivery Technologies include Sanofi, Eli Lilly and Company, Ypsomed, Julphar, Biocon and Becton, Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Drug and Delivery Technologies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Drug and Delivery Technologies market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Drug and Delivery Technologies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Drug and Delivery Technologies.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Drug and Delivery Technologies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Drug and Delivery Technologies Market by Company

Sanofi

Eli Lilly and Company

Ypsomed

Julphar

Biocon

Becton, Dickinson and Company

Insulin Drug and Delivery Technologies Segment by Type

Insulin Syringes

Insulin Vials

Insulin Pens

Insulin Pumps

Insulin Drug and Delivery Technologies Segment by Application

Diabetes Mellitus Type 1

Diabetes Mellitus Type 2

Gestational Diabetes

Insulin Drug and Delivery Technologies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Drug and Delivery Technologies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Drug and Delivery Technologies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Drug and Delivery Technologies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Drug and Delivery Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Syringes Table 2. Major Company of Insulin Vials Table 3. Major Company of Insulin Pens Table 4. Major Company of Insulin Pumps Table 5. Global Insulin Drug and Delivery Technologies Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 7. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type (2021-2026) Table 8. Global Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 9. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Type (2021-2026) Table 10. Global Insulin Drug and Delivery Technologies Price by Type (2021-2026) & (US$/unit) Table 11. Global Insulin Drug and Delivery Technologies Sales by Type (2027-2032) & (k units) Table 12. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type (2027-2032) Table 13. Global Insulin Drug and Delivery Technologies Sales by Type (2027-2032) & (US$ Million) Table 14. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Type (2027-2032) Table 15. Global Insulin Drug and Delivery Technologies Price by Type (2027-2032) & (US$/unit) Table 16. North America Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 17. North America Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 19. Europe Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 23. Latin America Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Type (2021-2026) & (US$ Million) Table 26. Insulin Drug and Delivery Technologies Industry Trends Table 27. Insulin Drug and Delivery Technologies Industry Drivers Table 28. Insulin Drug and Delivery Technologies Industry Opportunities and Challenges Table 29. Insulin Drug and Delivery Technologies Industry Restraints Table 30. Global Insulin Drug and Delivery Technologies Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Insulin Drug and Delivery Technologies Revenue Market Share by Company (2021-2026) Table 32. Global Insulin Drug and Delivery Technologies Sales by Company (2021-2026) & (k units) Table 33. Global Insulin Drug and Delivery Technologies Sales Share by Company (2021-2026) Table 34. Global Insulin Drug and Delivery Technologies Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Insulin Drug and Delivery Technologies Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Insulin Drug and Delivery Technologies Major Company Production Sites and Headquarters Table 37. Global Insulin Drug and Delivery Technologies Company, Product Type & Application Table 38. Global Insulin Drug and Delivery Technologies Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Insulin Drug and Delivery Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Insulin Drug and Delivery Technologies Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Insulin Drug and Delivery Technologies Sales by Region (2021-2026) & (k units) Table 43. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Region (2021-2026) Table 44. Global Insulin Drug and Delivery Technologies Sales by Region (2021-2026) & (US$ Million) Table 45. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Region (2021-2026) Table 46. Global Insulin Drug and Delivery Technologies Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Insulin Drug and Delivery Technologies Sales by Region (2027-2032) & (k units) Table 48. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Region (2027-2032) Table 49. Global Insulin Drug and Delivery Technologies Sales by Region (2027-2032) & (US$ Million) Table 50. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Region (2027-2032) Table 51. Global Insulin Drug and Delivery Technologies Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Insulin Drug and Delivery Technologies Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 54. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application (2021-2026) Table 55. Global Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 56. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Application (2021-2026) Table 57. Global Insulin Drug and Delivery Technologies Price by Application (2021-2026) & (US$/unit) Table 58. Global Insulin Drug and Delivery Technologies Sales by Application (2027-2032) & (k units) Table 59. Global Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application (2027-2032) Table 60. Global Insulin Drug and Delivery Technologies Sales by Application (2027-2032) & (US$ Million) Table 61. Global Insulin Drug and Delivery Technologies Sales Market Share in Value by Application (2027-2032) Table 62. Global Insulin Drug and Delivery Technologies Price by Application (2027-2032) & (US$/unit) Table 63. North America Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 64. North America Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 66. Europe Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 70. Latin America Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Insulin Drug and Delivery Technologies Product Portfolio Table 77. Sanofi Recent Development Table 78. Eli Lilly and Company Company Information Table 79. Eli Lilly and Company Business Overview Table 80. Eli Lilly and Company Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Eli Lilly and Company Insulin Drug and Delivery Technologies Product Portfolio Table 82. Eli Lilly and Company Recent Development Table 83. Ypsomed Company Information Table 84. Ypsomed Business Overview Table 85. Ypsomed Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Ypsomed Insulin Drug and Delivery Technologies Product Portfolio Table 87. Ypsomed Recent Development Table 88. Julphar Company Information Table 89. Julphar Business Overview Table 90. Julphar Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Julphar Insulin Drug and Delivery Technologies Product Portfolio Table 92. Julphar Recent Development Table 93. Biocon Company Information Table 94. Biocon Business Overview Table 95. Biocon Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Biocon Insulin Drug and Delivery Technologies Product Portfolio Table 97. Biocon Recent Development Table 98. Becton, Dickinson and Company Company Information Table 99. Becton, Dickinson and Company Business Overview Table 100. Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product Portfolio Table 102. Becton, Dickinson and Company Recent Development Table 103. North America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 104. North America Insulin Drug and Delivery Technologies Sales by Country (2021-2026) & (k units) Table 105. North America Insulin Drug and Delivery Technologies Sales Market Share by Country (2021-2026) Table 106. North America Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032) & (k units) Table 107. North America Insulin Drug and Delivery Technologies Sales Market Share Forecast by Country (2027-2032) Table 108. North America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Insulin Drug and Delivery Technologies Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Insulin Drug and Delivery Technologies Market Share by Country (2021-2026) Table 111. North America Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Insulin Drug and Delivery Technologies Market Share Forecast by Country (2027-2032) Table 113. Europe Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. Europe Insulin Drug and Delivery Technologies Sales by Country (2021-2026) & (k units) Table 115. Europe Insulin Drug and Delivery Technologies Sales Market Share by Country (2021-2026) Table 116. Europe Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032) & (k units) Table 117. Europe Insulin Drug and Delivery Technologies Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Insulin Drug and Delivery Technologies Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Insulin Drug and Delivery Technologies Market Share by Country (2021-2026) Table 121. Europe Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Insulin Drug and Delivery Technologies Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Country (2021-2026) & (k units) Table 125. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032) & (k units) Table 127. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Insulin Drug and Delivery Technologies Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Insulin Drug and Delivery Technologies Market Share by Country (2021-2026) Table 131. Asia-Pacific Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Insulin Drug and Delivery Technologies Market Share Forecast by Country (2027-2032) Table 133. Latin America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Latin America Insulin Drug and Delivery Technologies Sales by Country (2021-2026) & (k units) Table 135. Latin America Insulin Drug and Delivery Technologies Sales Market Share by Country (2021-2026) Table 136. Latin America Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032) & (k units) Table 137. Latin America Insulin Drug and Delivery Technologies Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Insulin Drug and Delivery Technologies Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Insulin Drug and Delivery Technologies Market Share by Country (2021-2026) Table 141. Latin America Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Insulin Drug and Delivery Technologies Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country (2021-2026) & (k units) Table 145. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032) & (k units) Table 147. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Insulin Drug and Delivery Technologies Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Insulin Drug and Delivery Technologies Market Share by Country (2021-2026) Table 151. Middle East and Africa Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Insulin Drug and Delivery Technologies Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Insulin Drug and Delivery Technologies Distributors List Table 156. Insulin Drug and Delivery Technologies Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Insulin Drug and Delivery Technologies Image Figure 2. Global Insulin Drug and Delivery Technologies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Drug and Delivery Technologies Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Drug and Delivery Technologies Sales (2021-2032) & (k units) Figure 5. Insulin Syringes Image Figure 6. Global Insulin Syringes Sales YoY Growth (2021-2032) & (k units) Figure 7. Insulin Vials Image Figure 8. Global Insulin Vials Sales YoY Growth (2021-2032) & (k units) Figure 9. Insulin Pens Image Figure 10. Global Insulin Pens Sales YoY Growth (2021-2032) & (k units) Figure 11. Insulin Pumps Image Figure 12. Global Insulin Pumps Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Insulin Drug and Delivery Technologies Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Insulin Drug and Delivery Technologies Market Share by Type 2025 VS 2032 Figure 15. North America Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type in 2025 Figure 16. North America Insulin Drug and Delivery Technologies Sales Market Share in Value by Type in 2025 Figure 17. Europe Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type in 2025 Figure 18. Europe Insulin Drug and Delivery Technologies Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share in Value by Type in 2025 Figure 21. Latin America Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Insulin Drug and Delivery Technologies Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Insulin Drug and Delivery Technologies Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Diabetes Mellitus Type 1 Image Figure 28. Global Diabetes Mellitus Type 1 Sales YoY Growth (2021-2032) & (k units) Figure 29. Diabetes Mellitus Type 2 Image Figure 30. Global Diabetes Mellitus Type 2 Sales YoY Growth (2021-2032) & (k units) Figure 31. Gestational Diabetes Image Figure 32. Global Gestational Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Insulin Drug and Delivery Technologies Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Insulin Drug and Delivery Technologies Market Share by Application 2025 VS 2032 Figure 35. North America Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application in 2025 Figure 36. North America Insulin Drug and Delivery Technologies Sales Market Share in Value by Application in 2025 Figure 37. Europe Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application in 2025 Figure 38. Europe Insulin Drug and Delivery Technologies Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Insulin Drug and Delivery Technologies Sales Market Share in Value by Application in 2025 Figure 41. Latin America Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Insulin Drug and Delivery Technologies Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Insulin Drug and Delivery Technologies Sales Market Share in Value by Application in 2025 Figure 45. North America Insulin Drug and Delivery Technologies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Insulin Drug and Delivery Technologies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Insulin Drug and Delivery Technologies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Insulin Drug and Delivery Technologies Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Insulin Drug and Delivery Technologies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Insulin Drug and Delivery Technologies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Insulin Drug and Delivery Technologies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Insulin Drug and Delivery Technologies Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Insulin Drug and Delivery Technologies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Insulin Drug and Delivery Technologies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Insulin Drug and Delivery Technologies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Insulin Drug and Delivery Technologies Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Insulin Drug and Delivery Technologies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Insulin Drug and Delivery Technologies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Insulin Drug and Delivery Technologies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Insulin Drug and Delivery Technologies Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Insulin Drug and Delivery Technologies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Insulin Drug and Delivery Technologies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Insulin Drug and Delivery Technologies Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Insulin Drug and Delivery Technologies Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Insulin Drug and Delivery Technologies Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Syringes
  • Insulin Vials
  • Insulin Pens
  • Insulin Pumps
Applications
  • Diabetes Mellitus Type 1
  • Diabetes Mellitus Type 2
  • Gestational Diabetes
Companies covered
  • Sanofi
  • Eli Lilly and Company
  • Ypsomed
  • Julphar
  • Biocon
  • Becton, Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Drug and Delivery Technologies Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Drug and Delivery Technologies Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Drug and Delivery Technologies Market by Type
  6. 1.3.1 Insulin Syringes
  7. 1.3.2 Insulin Vials
  8. 1.3.3 Insulin Pens
  9. 1.3.4 Insulin Pumps
  10. 1.4 Global Insulin Drug and Delivery Technologies Market Size by Type
  11. 1.4.1 Global Insulin Drug and Delivery Technologies Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Insulin Drug and Delivery Technologies Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Insulin Drug and Delivery Technologies Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Insulin Drug and Delivery Technologies Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Insulin Drug and Delivery Technologies Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Insulin Drug and Delivery Technologies Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Drug and Delivery Technologies Industry Trends
  2. 2.2 Insulin Drug and Delivery Technologies Industry Drivers
  3. 2.3 Insulin Drug and Delivery Technologies Industry Opportunities and Challenges
  4. 2.4 Insulin Drug and Delivery Technologies Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Drug and Delivery Technologies Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Drug and Delivery Technologies Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Drug and Delivery Technologies Price (2021-2026)
  4. 3.4 Global Insulin Drug and Delivery Technologies Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Drug and Delivery Technologies Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Drug and Delivery Technologies Company, Product Type & Application
  7. 3.7 Global Insulin Drug and Delivery Technologies Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Drug and Delivery Technologies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Drug and Delivery Technologies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Drug and Delivery Technologies Tier 1, Tier 2, and Tier 3
4 Insulin Drug and Delivery Technologies Regional Status and Outlook
  1. 4.1 Global Insulin Drug and Delivery Technologies Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Drug and Delivery Technologies Historic Market Size by Region
  3. 4.2.1 Global Insulin Drug and Delivery Technologies Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Drug and Delivery Technologies Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Drug and Delivery Technologies Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Drug and Delivery Technologies Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Drug and Delivery Technologies Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Drug and Delivery Technologies Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Drug and Delivery Technologies by Application
  1. 5.1 Insulin Drug and Delivery Technologies Market by Application
  2. 5.1.1 Diabetes Mellitus Type 1
  3. 5.1.2 Diabetes Mellitus Type 2
  4. 5.1.3 Gestational Diabetes
  5. 5.2 Global Insulin Drug and Delivery Technologies Market Size by Application
  6. 5.2.1 Global Insulin Drug and Delivery Technologies Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin Drug and Delivery Technologies Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin Drug and Delivery Technologies Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin Drug and Delivery Technologies Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin Drug and Delivery Technologies Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin Drug and Delivery Technologies Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Insulin Drug and Delivery Technologies Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Ypsomed
  14. 6.3.1 Ypsomed Company Information
  15. 6.3.2 Ypsomed Business Overview
  16. 6.3.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ypsomed Insulin Drug and Delivery Technologies Product Portfolio
  18. 6.3.5 Ypsomed Recent Developments
  19. 6.4 Julphar
  20. 6.4.1 Julphar Company Information
  21. 6.4.2 Julphar Business Overview
  22. 6.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Julphar Insulin Drug and Delivery Technologies Product Portfolio
  24. 6.4.5 Julphar Recent Developments
  25. 6.5 Biocon
  26. 6.5.1 Biocon Company Information
  27. 6.5.2 Biocon Business Overview
  28. 6.5.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Biocon Insulin Drug and Delivery Technologies Product Portfolio
  30. 6.5.5 Biocon Recent Developments
  31. 6.6 Becton, Dickinson and Company
  32. 6.6.1 Becton, Dickinson and Company Company Information
  33. 6.6.2 Becton, Dickinson and Company Business Overview
  34. 6.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product Portfolio
  36. 6.6.5 Becton, Dickinson and Company Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Drug and Delivery Technologies Sales by Country
  2. 7.1.1 North America Insulin Drug and Delivery Technologies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Drug and Delivery Technologies Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Drug and Delivery Technologies Market Size by Country
  6. 7.2.1 North America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Drug and Delivery Technologies Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Drug and Delivery Technologies Sales by Country
  2. 8.1.1 Europe Insulin Drug and Delivery Technologies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Drug and Delivery Technologies Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Drug and Delivery Technologies Market Size by Country
  6. 8.2.1 Europe Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Drug and Delivery Technologies Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Drug and Delivery Technologies Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Drug and Delivery Technologies Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Drug and Delivery Technologies Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Drug and Delivery Technologies Sales by Country
  2. 10.1.1 South America Insulin Drug and Delivery Technologies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Drug and Delivery Technologies Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Drug and Delivery Technologies Market Size by Country
  6. 10.2.1 South America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Drug and Delivery Technologies Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Drug and Delivery Technologies Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Drug and Delivery Technologies Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Drug and Delivery Technologies Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Drug and Delivery Technologies Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Drug and Delivery Technologies Value Chain Analysis
  2. 12.1.1 Insulin Drug and Delivery Technologies Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Drug and Delivery Technologies Production Mode & Process
  7. 12.2 Insulin Drug and Delivery Technologies Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Drug and Delivery Technologies Distributors
  10. 12.2.3 Insulin Drug and Delivery Technologies Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst